Video Library
Working Together on Alzheimer’s Research
ATRI and ACTC study where the science is moving on Alzheimer's disease [AD] treatment and how to move it faster. ATRI conducts trials and partners with research teams around the United States. It's a network of first-in-class, best-in-class clinical trial experts who...
Working Together on Alzheimer’s Research
ATRI and ACTC study where the science is moving on Alzheimer's disease [AD] treatment and how to move it faster. ATRI conducts trials and partners with research teams around the United States. It's a network of first-in-class, best-in-class clinical trial experts who...
Biomarkers & How They Help Diagnose Dementia
Biomarkers are measurable indicators of what’s happening in your body. They can be found in blood, other body fluids, organs, and tissues, and can be used to track healthy processes, disease progression, or even responses to medication. When combined with other tests,...
Leading The Charge On Effective New Treatments For Alzheimer’s Disease
Wall Street Journal has a new video on how Biogen’s Aduhelm is the first approved treatment for early-stage Alzheimer’s patients and that it may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to...
Generous Gifts Make Alzheimer’s Disease Research Possible
ATRI – Preventing Dementia by Preventing Stroke
Wall Street Journal has a new video on how Biogen’s Aduhelm is the first approved treatment for early-stage Alzheimer’s patients and that it may be able to slow the disease. WSJ explains how the drug interacts with brain cells, and why some doctors aren’t ready to...
ATRI World Alzheimer’s Day Event 2022
Zandra Rhodes Event
How Science, Culture, and Polit…ed a Rare Disease into a Crisis and What We Can Do about It
Watch Ad Experts Talk About The Latest Research On Facebook Live
There have been many developments lately in potential Alzheimer’s treatments. So to mark Alzheimer’s and Brain Awareness Month, USC conducted a Facebook Live panel discussion with Michael Rafii, MD, PhD, associate professor of clinical neurology and medical director...
The Problem of Alzheimer’s
On June 30, 2021, USC Alzheimer’s Therapeutic Research Institute's Michael Rafii, MD, PhD, and Alzheimer's Clinical Trial Consortium (ACTC) colleague Jason Karlawish, MD, met for a discussion of Karlawish's recent bookThe Problem of Alzheimer's: How Science, Culture,...